Tocilizumab in refractory Caucasian Takayasu’s arteritis: a multicenter study of 54 patients and literature review

Objective: To assess the efficacy and safety of tocilizumab (TCZ) in Caucasian patients with refractory Takayasu’s arteritis (TAK) in clinical practice. Methods: A multicenter study of Caucasian patients with refractory TAK who received TCZ. The outcome variables were remission, glucocorticoid-spari...

Full description

Bibliographic Details

Published in:	Therapeutic Advances in Musculoskeletal Disease
Main Authors:	Diana Prieto-Peña, Pilar Bernabeu, Paloma Vela, Javier Narváez, Jesús C. Fernández-López, Mercedes Freire-González, Beatriz González-Álvarez, Roser Solans-Laqué, José L. Callejas Rubio, Norberto Ortego, Carlos Fernández-Díaz, Esteban Rubio, Salvador García-Morillo, Mauricio Minguez, Cristina Fernández-Carballido, Eugenio de Miguel, Sheila Melchor, Eva Salgado, Beatriz Bravo, Susana Romero-Yuste, Juan Salvatierra, Cristina Hidalgo, Sara Manrique, Carlos Romero-Gómez, Patricia Moya, Noelia Álvarez-Rivas, Javier Mendizabal, Francisco Ortiz-Sanjuán, Iván Pérez de Pedro, José L. Alonso-Valdivielso, Laura Perez-Sanchez, Rosa Roldán, Nagore Fernandez-Llanio, Ricardo Gómez de la Torre, Silvia Suarez, María Jesús Montesa Cabrera, Mónica Delgado Sánchez, Javier Loricera, Belén Atienza-Mateo, Santos Castañeda, Miguel A. González-Gay, Ricardo Blanco
Format:	Article
Language:	English
Published:	SAGE Publishing 2021-06-01
Online Access:	https://doi.org/10.1177/1759720X211020917